David Mischoulon
David Mischoulon
Massachusetts General Hospital
在 partners.org 的電子郵件地址已通過驗證
標題引用次數年份
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
MP Freeman, JR Hibbeln, KL Wisner, JM Davis, D Mischoulon, M Peet, ...
Journal of Clinical Psychiatry 67 (12), 1954, 2006
8262006
Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence
D Mischoulon, M Fava
The American journal of clinical nutrition 76 (5), 1158S-1161S, 2002
3312002
Quality of life assessments in major depressive disorder: a review of the literature
GI Papakostas, T Petersen, Y Mahal, D Mischoulon, AA Nierenberg, ...
General hospital psychiatry 26 (1), 13-17, 2004
3042004
Nutritional medicine as mainstream in psychiatry
J Sarris, AC Logan, TN Akbaraly, GP Amminger, V Balanzá-Martínez, ...
The Lancet Psychiatry 2 (3), 271-274, 2015
2442015
S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind …
GI Papakostas, D Mischoulon, I Shyu, JE Alpert, M Fava
American Journal of Psychiatry 167 (8), 942-948, 2010
2362010
Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early …
B Rana, D Mischoulon, Y Xie, NL Bucher, SR Farmer
Molecular and cellular biology 14 (9), 5858-5869, 1994
2361994
Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
J Sarris, D Mischoulon, I Schweitzer
The Journal of clinical psychiatry 73 (1), 81-86, 2012
2282012
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials
GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ...
American Journal of Psychiatry 169 (12), 1267-1274, 2012
2022012
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
RH Perlis, D Mischoulon, JW Smoller, YJY Wan, S Lamon-Fava, KM Lin, ...
Biological psychiatry 54 (9), 879-883, 2003
1922003
Nutrition and depression: focus on folate.
JE Alpert, D Mischoulon, AA Nierenberg, M Fava
Nutrition (Burbank, Los Angeles County, Calif.) 16 (7-8), 544, 2000
1902000
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder
M Fava, J Alpert, AA Nierenberg, D Mischoulon, MW Otto, J Zajecka, ...
Journal of clinical psychopharmacology 25 (5), 441-447, 2005
1882005
Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture.
D Mischoulon, B Rana, NL Bucher, SR Farmer
Molecular and cellular biology 12 (6), 2553-2560, 1992
1631992
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression
JE Alpert, D Mischoulon, GEF Rubenstein, K Bottonari, AA Nierenberg, ...
Annals of Clinical Psychiatry 14 (1), 33-38, 2002
1612002
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors …
JE Alpert, G Papakostas, D Mischoulon, JJ Worthington III, T Petersen, ...
Journal of clinical psychopharmacology 24 (6), 661-664, 2004
1482004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
GI Papakostas, T Petersen, D Mischoulon, JL Ryan, AA Nierenberg, ...
The Journal of clinical psychiatry 65 (8), 1090-1095, 2004
1352004
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses
GI Papakostas, D Öngür, DV Iosifescu, D Mischoulon, M Fava
European Neuropsychopharmacology 14 (2), 135-142, 2004
1352004
Adjunctive nutraceuticals for depression: a systematic review and meta-analyses
J Sarris, J Murphy, D Mischoulon, GI Papakostas, M Fava, M Berk, CH Ng
American Journal of Psychiatry 173 (6), 575-587, 2016
1272016
Folate in depression: efficacy, safety, differences in formulations, and clinical issues.
M Fava, D Mischoulon
Journal of Clinical Psychiatry 70 (5), 12-17, 2009
1262009
A double‐blind, randomized, pilot dose‐finding study of maca root (L. meyenii) for the management of SSRI‐induced sexual dysfunction
CM Dording, L Fisher, G Papakostas, A Farabaugh, S Sonawalla, M Fava, ...
CNS neuroscience & therapeutics 14 (3), 182-191, 2008
1212008
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists
CM Dording, D Mischoulon, TJ Petersen, R Kornbluh, J Gordon, ...
Annals of Clinical Psychiatry 14 (3), 143-147, 2002
1212002
系統目前無法執行作業,請稍後再試。
文章 1–20